Literature DB >> 15981087

CD4+ T cells downregulate Bcl-2 in germinal centers.

André Almeida Schenka1, Sabina Müller, Jean-Jacques Fournié, Florence Capila, José Vassallo, Georges Delsol, Salvatore Valitutti, Pierre Brousset.   

Abstract

Germinal centers (GCs) are the main site of T cell-dependent antibody responses. Upon antigen challenge, GCs comprise mostly B cells undergoing proliferation, somatic hypermutation and antigen-affinity selection. GC B cells down-modulate the expression of Bcl-2 protein and are highly sensitive to apoptosis to eliminate autoreactive or low-affinity cells. Bcl-2 is still expressed in a few GC cells, whose identity remains unclear. To address this issue, we examined by confocal microscopy the expression of Bcl-2 by different GC lymphocyte subsets in hyperplastic tonsils. We found that the vast majority of Bcl-2(+) GC cells are T lymphocytes. Conversely, while in the mantle zone and in the interfollicular areas T cells are almost exclusively Bcl-2(+), in the GC, most T lymphocytes are Bcl-2(-). In addition, most of the CD4(+) GC T cells are Bcl-2(-), while nearly 100% of the CD8(+) GC T cells are Bcl-2(+). The Bcl-2 downregulation by both B and CD4(+) T GC cells supports the concept that these two subsets may undergo a selection process in this microenvironment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981087     DOI: 10.1007/s10875-005-4084-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

Review 1.  New insights to the functional role of the T cell-antigen presenting cell immunological synapse.

Authors:  Mustapha Faroudi; Rossana Zaru; Benoit Favier; Salvatore Valitutti
Journal:  Biol Res       Date:  2002       Impact factor: 5.612

Review 2.  Life-or-death decisions by the Bcl-2 protein family.

Authors:  J M Adams; S Cory
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

3.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Differential expression of Fas antigen and Bcl-2 protein on CD4+ T cells, CD8+ T cells, and monocytes.

Authors:  S Shinohara; T Sawada; Y Nishioka; S Tohma; T Kisaki; T Inoue; K Ando; M Ikeda; H Fujii; K Ito
Journal:  Cell Immunol       Date:  1995-07       Impact factor: 4.868

5.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

6.  bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.

Authors:  J Gratiot-Deans; L Ding; L A Turka; G Nuñez
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

Review 7.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.

Authors:  M Pettersson; H Jernberg-Wiklund; L G Larsson; C Sundström; I Givol; Y Tsujimoto; K Nilsson
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

9.  Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2.

Authors:  H Martinez-Valdez; C Guret; O de Bouteiller; I Fugier; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.

Authors:  A N Akbar; N Borthwick; M Salmon; W Gombert; M Bofill; N Shamsadeen; D Pilling; S Pett; J E Grundy; G Janossy
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity.

Authors:  Di Yu; Carola G Vinuesa
Journal:  Cell Mol Immunol       Date:  2010-04-05       Impact factor: 11.530

2.  Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Authors:  Kichul Ko; Jianing Wang; Stuart Perper; Yulei Jiang; Denisse Yanez; Natalya Kaverina; Junting Ai; Vladimir M Liarski; Anthony Chang; Yahui Peng; Li Lan; Susan Westmoreland; Lisa Olson; Maryellen L Giger; Li Chun Wang; Marcus R Clark
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.